Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Pharmaceuticals and Biotech
Recent news which mentions Pharmaceuticals and Biotech
< Previous
1
2
Next >
Privo Technologies, Inc. Awarded $3M NIDCR NIH Commercialization Readiness Pilot Grant
August 23, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
August 23, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Privo Technologies Named Winner of AIM-HI Accelerator Fund's Inaugural Women's Venture Competition
August 19, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
John Wainwright PhD Joins MIVI Neuroscience as Vice President, R&D
August 18, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Woodward Pharma Services LLC Acquires LOVAZA® Capsules
August 17, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Unique Approach Secures Access to Orphan Medication With a Complex PA for 68% of 'Unfillable' Prescriptions
August 17, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Royal Biologics Announces Partnership With Vilex Launching Its ALC Technology Into Lower Extremity Industry
August 17, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
ClinEdge & Skylight Health Expand Partnership
August 16, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Vanessa Ribreau Joins BenchSci as Chief People Officer to Lead Company's Embrace of the Future of Work
August 11, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
New NCQA Program Highlights Specialty Pharmacies for Commitment to Quality
August 10, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Enterin Announces Appointment of Alan Moses to Its Scientific Advisory Board
August 10, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Amplity's Chief People Officer Named Delaware Valley Human Resources Person of the Year
August 09, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
SiO2's Materials Science Receives $64 Million Contract From U.S. Gov to Support Additional Scale Up of Advanced Primary Packaging Platform for Biological Drugs and Vaccines
August 04, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Natural Hormone Replacement Therapy Paves New Path for Treatment at Nova Vita Wellness Centers
August 04, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Enalare Therapeutics Expands Its Scientific Team With Appointment of Thomas Miller, PhD, as Vice President of Clinical Development
August 04, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
ICE Global Consulting, Inc and Ledger Run, Inc Form Strategic Partnership
August 03, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
SiO2 Materials Science Names Paul Fehlman as Chief Financial Officer
August 03, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Ethisphere Leads APEC Effort to Measure the Impact of Doing Business With Integrity in the Asia Pacific Region
August 03, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
GeneTex Develops Recombinant Influenza Nucleoprotein Antibodies as Potential Diagnostics
August 02, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Health Canada Grants No Objection Letter to Epygenix Therapeutics to Proceed With ARGUS Trial for the Treatment of Dravet Syndrome
August 02, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Epygenix Therapeutics Receives U.S. FDA Orphan Drug Designation for EPX-200 in Lennox-Gastaut Syndrome
August 02, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Epygenix Therapeutics Receives Orphan Medicinal Product Designation in Europe With EPX-200 for the Treatment of Patients With Dravet Syndrome
August 02, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
'What the Health?': The Drug Price Dilemma
July 29, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Over 100 Validated Xenograft Models for IND Efficacy Testing. Preclinical GLP Research Services by Altogen Labs
July 28, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
OnePoint Patient Care to Open Pittsburgh, PA, Hospice-Dedicated Pharmacy
July 28, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
BenchSci Extends Impact on Drug Discovery With Addition of AI-Assisted Animal Model Selection
July 28, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
The Branford Group to Conduct Auction of Leading Genomic Testing Lab CQuentia in Memphis
July 23, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
Paramita Therapeutics, Inc. Awarded Competitive Grant From the National Science Foundation
July 21, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
RxCelerate Establishes Venture Capital Division and Makes First Investment in US Metabolic Disease Company
July 20, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
BenchSci Expands Board of Directors With Appointment of Life Sciences, Tech, and Healthcare Leader Luba Greenwood
July 20, 2021
Tags
Pharmaceuticals and Biotech
From
Latest Press Releases from Newswire.com
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.